Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment

MiR-34a acts as tumor suppressor microRNA (miRNA) in several cancers, including multiple myeloma (MM), by controlling the expression of target proteins involved in cell cycle, differentiation and apoptosis. Here, we have investigated the combination between miR-34a and γ-secretase inhibitor (γSI), S...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Sci Rep
Glavni autori: Zarone, Mayra Rachele, Misso, Gabriella, Grimaldi, Anna, Zappavigna, Silvia, Russo, Margherita, Amler, Evzen, Di Martino, Maria Teresa, Amodio, Nicola, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Caraglia, Michele
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738363/
https://ncbi.nlm.nih.gov/pubmed/29263373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-18186-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items